UP - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources UPUK. For full access, REGISTER.

1 2 3 4 5
hits: 183
1.
Full text

PDF
2.
  • SWOG S0809: A Phase II Inte... SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
    Ben-Josef, Edgar; Guthrie, Katherine A; El-Khoueiry, Anthony B ... Journal of clinical oncology, 08/2015, Volume: 33, Issue: 24
    Journal Article
    Peer reviewed
    Open access

    The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival (overall and after R0 or R1 ...
Full text

PDF
3.
  • Sex Differences in Risk of ... Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
    Unger, Joseph M; Vaidya, Riha; Albain, Kathy S ... Journal of clinical oncology, 05/2022, Volume: 40, Issue: 13
    Journal Article
    Peer reviewed
    Open access

    Women have more adverse events (AEs) from chemotherapy than men, but few studies have investigated sex differences in immune or targeted therapies. We examined AEs by sex across different treatment ...
Full text

PDF
4.
  • A Phase II Basket Trial of ... A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
    Patel, Sandip P; Othus, Megan; Chae, Young Kwang ... Clinical cancer research, 05/2020, Volume: 26, Issue: 10
    Journal Article
    Peer reviewed
    Open access

    Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine ...
Full text

PDF
5.
  • Safeguards for medical aid ... Safeguards for medical aid in dying
    Blanke, Charles D British journal of hospital medicine (London, England : 2005), 2024-Feb-02, Volume: 85, Issue: 2
    Journal Article
    Peer reviewed
Check availability
6.
  • Updated analysis of SWOG-di... Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection
    Smalley, Stephen R; Benedetti, Jacqueline K; Haller, Daniel G ... Journal of clinical oncology, 07/2012, Volume: 30, Issue: 19
    Journal Article
    Peer reviewed
    Open access

    Surgical resection of gastric cancer has produced suboptimal survival despite multiple randomized trials that used postoperative chemotherapy or more aggressive surgical procedures. We performed a ...
Full text

PDF
7.
  • Survival in Young-Onset Met... Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405
    Lipsyc-Sharf, Marla; Zhang, Sui; Ou, Fang-Shu ... JNCI : Journal of the National Cancer Institute, 03/2022, Volume: 114, Issue: 3
    Journal Article
    Peer reviewed
    Open access

    Abstract Background The incidence of young-onset colorectal cancer (yoCRC) is increasing. It is unknown if there are survival differences between young and older patients with metastatic colorectal ...
Full text
8.
  • Mutational Analysis of Pati... Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
    Innocenti, Federico; Ou, Fang-Shu; Qu, Xueping ... Journal of clinical oncology, 05/2019, Volume: 37, Issue: 14
    Journal Article
    Peer reviewed
    Open access

    CALGB/SWOG 80405 was a randomized phase III trial that found no statistically significant difference in overall survival (OS) in patients with first-line metastatic colorectal cancer treated with ...
Full text

PDF
9.
  • Impact of Consensus Molecul... Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
    Lenz, Heinz-Josef; Ou, Fang-Shu; Venook, Alan P ... Journal of clinical oncology, 08/2019, Volume: 37, Issue: 22
    Journal Article
    Peer reviewed
    Open access

    To determine the predictive and prognostic value of the consensus molecular subtypes (CMSs) of colorectal cancer (CRC) that represent a merging of gene expression-based features largely in primary ...
Full text

PDF
10.
  • Imatinib plasma levels are ... Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors
    Demetri, George D; Wang, Yanfeng; Wehrle, Elisabeth ... Journal of clinical oncology, 07/2009, Volume: 27, Issue: 19
    Journal Article
    Peer reviewed
    Open access

    PURPOSE To study the pharmacokinetics (PK) of imatinib (IM) in patients with advanced GI stromal tumors (GISTs) treated in a randomized phase II study and to explore the potential relationship ...
Full text
1 2 3 4 5
hits: 183

Load filters